Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 3
1982 1
1983 1
1984 2
1985 5
1987 5
1988 4
1989 4
1990 2
1991 5
1992 7
1993 2
1994 8
1995 9
1996 6
1997 11
1998 8
1999 14
2000 6
2001 10
2002 11
2003 9
2004 11
2005 11
2006 4
2007 11
2008 9
2009 15
2010 13
2011 21
2012 17
2013 21
2014 22
2015 16
2016 19
2017 15
2018 18
2019 16
2020 16
2021 21
2022 25
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

388 results
Results by year
Filters applied: . Clear all
Page 1
Defining the clinical course of multiple sclerosis: the 2013 revisions.
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Lublin FD, et al. Among authors: pozzilli c. Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28. Neurology. 2014. PMID: 24871874 Free PMC article.
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial.
Kappos L, Fox RJ, Burcklen M, Freedman MS, Havrdová EK, Hennessy B, Hohlfeld R, Lublin F, Montalban X, Pozzilli C, Scherz T, D'Ambrosio D, Linscheid P, Vaclavkova A, Pirozek-Lawniczek M, Kracker H, Sprenger T. Kappos L, et al. Among authors: pozzilli c. JAMA Neurol. 2021 May 1;78(5):558-567. doi: 10.1001/jamaneurol.2021.0405. JAMA Neurol. 2021. PMID: 33779698 Free PMC article. Clinical Trial.
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies.
Iaffaldano P, Lucisano G, Caputo F, Paolicelli D, Patti F, Zaffaroni M, Brescia Morra V, Pozzilli C, De Luca G, Inglese M, Salemi G, Maniscalco GT, Cocco E, Sola P, Lus G, Conte A, Amato MP, Granella F, Gasperini C, Bellantonio P, Totaro R, Rovaris M, Salvetti M, Torri Clerici VLA, Bergamaschi R, Maimone D, Scarpini E, Capobianco M, Comi G, Filippi M, Trojano M; Italian MS Register. Iaffaldano P, et al. Among authors: pozzilli c. Ther Adv Neurol Disord. 2021 May 31;14:17562864211019574. doi: 10.1177/17562864211019574. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34104220 Free PMC article.
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis.
Portaccio E, Fonderico M, Iaffaldano P, Pastò L, Razzolini L, Bellinvia A, De Luca G, Ragonese P, Patti F, Brescia Morra V, Cocco E, Sola P, Inglese M, Lus G, Pozzilli C, Maimone D, Lugaresi A, Gazzola P, Comi G, Pesci I, Spitaleri D, Rezzonico M, Vianello M, Avolio C, Logullo FO, Granella F, Salvetti M, Zaffaroni M, Lucisano G, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis Register Centers Group. Portaccio E, et al. Among authors: pozzilli c. JAMA Neurol. 2022 Sep 1;79(9):869-878. doi: 10.1001/jamaneurol.2022.1929. JAMA Neurol. 2022. PMID: 35877104 Clinical Trial.
Ponesimod to treat multiple sclerosis.
Ianniello A, Pozzilli C. Ianniello A, et al. Among authors: pozzilli c. Drugs Today (Barc). 2021 Dec;57(12):745-758. doi: 10.1358/dot.2021.57.12.3353166. Drugs Today (Barc). 2021. PMID: 34909803 Review.
Corticosteroids treatment.
Pozzilli C, Marinelli F, Romano S, Bagnato F. Pozzilli C, et al. J Neurol Sci. 2004 Aug 15;223(1):47-51. doi: 10.1016/j.jns.2004.04.019. J Neurol Sci. 2004. PMID: 15261560 Review.
Multiple Sclerosis Treatment and Melanoma Development.
Carbone ML, Lacal PM, Messinese S, De Giglio L, Pozzilli C, Persechino S, Mazzanti C, Failla CM, Pagnanelli G. Carbone ML, et al. Among authors: pozzilli c. Int J Mol Sci. 2020 Apr 22;21(8):2950. doi: 10.3390/ijms21082950. Int J Mol Sci. 2020. PMID: 32331328 Free PMC article. Review.
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in.
Pugliatti M, Hartung HP, Oreja-Guevara C, Pozzilli C, Airas L, Alkhawajah M, Grigoriadis N, Magyari M, Van Wijmeersch B, Zakaria M, Linker R, Chan A, Vermersch P, Berger T. Pugliatti M, et al. Among authors: pozzilli c. Front Immunol. 2022 Oct 17;13:1045101. doi: 10.3389/fimmu.2022.1045101. eCollection 2022. Front Immunol. 2022. PMID: 36325318 Free PMC article. Review.
Assessing walking disability in multiple sclerosis.
Kieseier BC, Pozzilli C. Kieseier BC, et al. Among authors: pozzilli c. Mult Scler. 2012 Jul;18(7):914-24. doi: 10.1177/1352458512444498. Epub 2012 Apr 24. Mult Scler. 2012. PMID: 22740603 Review.
388 results